Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Brazil's health watchdog gives nod to HIV vaccine

Summary by Merco Press
Brazil's Health Regulatory Agency (Anvisa) approved on Monday the use of the drug Sunlenca (lenacapavir) for HIV-1 prevention as pre-exposure prophylaxis (PrEP), Agencia Brasil reported.

2 Articles

Merco PressMerco Press
Lean Left

Brazil's health watchdog gives nod to HIV vaccine

Brazil's Health Regulatory Agency (Anvisa) approved on Monday the use of the drug Sunlenca (lenacapavir) for HIV-1 prevention as pre-exposure prophylaxis (PrEP), Agencia Brasil reported.

·Caracas, Venezuela, Bolivarian Republic of
Read Full Article
GloboGlobo

Advise Approved Lenacapavir Injectable for Hiv Prevention

Medicine is an additional pre-exposure prevention option for HIV (PREP). Studies published in 2024 show that drug is 100% effective in preventing disease.

·Brazil
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Globo broke the news in Brazil on Monday, January 12, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Americas icon

Americas

South America icon

South America

Latin America icon

Latin America

HIV icon

HIV

Medical icon

Medical

Brazil icon

Brazil

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal